Tirzepatide For weight loss, glucose control, and cardiometabolic benefits
Thirdly, the class of GLP1-RA medications are restricted within the VHA system and require pharmacy approval or endocrinology consultation 48 , which may have resulted in potential heterogeneity between the GLP1-RA and DPP4i group
Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, Novak K, Wober C, Pemp B, Bsteh G (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension
Divide evenly among 4 serving dishes and refrigerate for 2 hours, or until set
POMC, Proopiomelanocortin